Avoro Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $96.1M | Sell |
|
|||||
|
2024
Q3 | $143M | Sell |
|
|||||
|
2024
Q2 | $375M | Buy |
|
|||||
|
2024
Q1 | $381M | Buy |
|
|||||
|
2023
Q4 | $415M | Buy |
|
|||||
|
2023
Q3 | $341M | Sell |
|
|||||
|
2023
Q2 | $347M | Buy |
|
|||||
|
2023
Q1 | $384M | Buy |
|
|||||
|
2022
Q4 | $368M | Hold |
|
|||||
|
2022
Q3 | $301M | Buy |
|
|||||
|
2022
Q2 | $272M | Buy |
|
|||||
|
2022
Q1 | $234M | Buy |
|
|||||
|
2021
Q4 | $247M | Buy |
|
|||||
|
2021
Q3 | $145M | Buy |
|
|||||
|
2021
Q2 | $138M | Hold |
|
|||||
|
2021
Q1 | $125M | Hold |
|
|||||
|
2020
Q4 | $145M | Sell |
|
|||||
|
2020
Q3 | $133M | Sell |
|
|||||
|
2020
Q2 | $228M | Sell |
|
|||||
|
2020
Q1 | $163M | Sell |
|
|||||
|
2019
Q4 | $169M | Sell |
|
|||||
|
2019
Q3 | $164M | Buy |
|
|||||
|
2019
Q2 | $181M | Buy |
|
|||||
|
2019
Q1 | $99.5M | Sell |
|
|||||
|
2018
Q4 | $116M | Sell |
|
|||||
|
2018
Q3 | $133M | Sell |
|
|||||
|
2018
Q2 | $153M | Sell |
|
|||||
|
2018
Q1 | $139M | Buy |
|
|||||
|
2017
Q4 | $106M | Buy |
|
|||||
|
2017
Q3 | $55.7M | Buy |
|
|||||
|
2017
Q2 | $45.5M | Sell |
|
|||||
|
2017
Q1 | $51.8M | Buy |
|
|||||
|
2016
Q4 | $33.1M | Sell |
|
|||||
|
2016
Q3 | $38.8M | Sell |
|
|||||
|
2016
Q2 | $33.7M | Buy |
|
|||||
|
2016
Q1 | $22.9M | Buy |
|